Sponsor Dossier
Eugia Pharma
Sponsor Dossier for Eugia Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AZACITIDINE
- Brand: BENDAMUSTINE
- Brand: BORTEZOMIB
- Brand: CARBOPLATIN
- Brand: EUG-AZACITIDINE
- Brand: EUG-BENDAMUSTINE
- Brand: EUG-BORTEZOMIB
- Brand: EUG-CARBOPLATIN
About
Eugia Pharma is an Australian Private Company with ABN 57656083028, registered in Victoria. The company is currently active and GST-registered.
Portfolio
Eugia Pharma has 19 brands on the ARTG, of which 8 are indexable and 8 have Product Information on file. The portfolio includes 2 brands with PBAC outcomes on record. No brands in the portfolio are currently PBS-listed, and no brands have AusPARs on record.
Therapeutic focus —
Oncology: 17 brands — Infectious Disease: 2 brands
Regulatory activity
The most recent PBAC outcome for Eugia Pharma's portfolio was recorded in September 2022, with 2 brands having PBAC outcomes on record.